Back to Trades
Grant4
Xylem Inc.
XYL
Total Value
$10.3M
Grants
$1.9M
5 transactions
Company Information
- Company Name
- Xylem Inc.
- Ticker Symbol
- XYL
- CIK
- 0001524472
Insider Information
- Role
- Pres. & CEO, Director
- Location
- WASHINGTON, DC
DirectorOfficer
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Mar 1, 2026
- Accession Number
- 0001524472-26-000040
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 1, 2026 | Common Stock | 5,243 | $128.98 | Grant/Award | $676.2K |
| Mar 1, 2026 | Common Stock | 4,328 | $128.98 | Grant/Award | $558.2K |
| Mar 1, 2026 | Common Stock | 2,943 | $128.98 | Grant/Award | $379.6K |
| Mar 1, 2026 | Common Stock | 2,152 | $128.98 | Grant/Award | $277.6K |
| Mar 2, 2026 | Common Stock | 16,105 | — | Grant/Award | — |
| Mar 2, 2026 | Common Stock | 4,927 | $128.98 | Tax Withholding | $635.5K |
| Mar 2, 2026 | Common Stock | 847 | $128.98 | Tax Withholding | $109.2K |
| Mar 2, 2026 | Common Stock | 2,316 | $128.98 | Tax Withholding | $298.7K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Derivative | 57,386 | $128.98 | Grant/Award | $7.4M |
Footnotes
- (F1)Reflects the acquisition of 5,243 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
- (F2)Includes additional shares due to dividend reinvestment.
- (F3)Reflects the acquisition of 4,328 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
- (F4)Reflects the acquisition of 2,943 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
- (F5)Reflects the acquisition of 2,152 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.
- (F6)Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
- (F7)Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
- (F8)Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
- (F9)Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (649) and March 1, 2024 (1,667) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
- (F10)Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.